Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
Condition: Chronic Phase Philadelphia Positive · BCR-ABL Positive · Chronic Myeloid Leukaemia · Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
About this study
The GIMEMA CML Working Party promotes a multicentre, observational, prospective study of CML patients treated frontline with NIL. Patients will be followed for 5 years. This study will help the definition of guidelines for the treatment of CML patients in early CP.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (56)
| S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo | Alessandria, Italy | — |
| Azienda Ospedaliera Nuovo Ospedale "Torrette" | Ancona, Italy | — |
| Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" | Ascoli Piceno, Italy | — |
| Ematologia con trapianto-Università degli Studi di Bari Aldo Moro | Bari, Italy | — |
| Policlinico Sant'Orsola Malpighi | Bologna, Italy | — |
| USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia | Brescia, Italy | — |
| Divisione di Ematologia Ospedale A. Perrino | Brindisi, Italy | — |
| ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO | Cagliari, Italy | — |
| U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche | Campobasso, Italy | — |
| US Dipartimentale - Centro per le malattie del sangue - Ospedale Civile - S.Giacomo | Castelfranco Veneto, Italy | — |
| ezione di Ematologia C.T.M.O. Istituti Ospitalieri | Cremona, Italy | — |
| Ospedale Santa Croce Divisione di Ematologia Cuneo | Cuneo, Italy | — |
+ 44 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01699217